Global pharma conglomerates are always looking to expand their pipelines all the time - one only has to look at Roche's CEO's comments today and of course we know their current R & D pipeline includes Heart Failure ... I think we are vulnerable down here so I guess we are lucky that Gregory and Silviu have such a large holding between them ... GLTAH
https://endpts.com/roche-ceo-outlines-new-rd-strategy-after-years-of-late-stage-trial-failures/
Roche CEO outlines new R&D strategy after years of late-stage trial failures
New Roche CEO Thomas Schinecker is implementing a refined R&D strategy for the sprawling Swiss conglomerate in the wake of several recent late-stage failures.
The new goals aim to ensure pipeline programs can move more efficiently from early-stage to late-stage, while the company also hunts for deals on drugs already being tested in human trials, Schinecker said Monday during Roche’s Pharma Day in London.
“We need to deliver value fast, and that’s the mentality we want in the organization,” the CEO said.
Cell Therapy News/Articles, page-16776
-
- There are more pages in this discussion • 1,142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 96.0¢ | $1.141M | 1.173M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 192210 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.5¢ | 47506 | 14 |
View Market Depth
| Last trade - 11.50am 13/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |